DVA [NYSE]
DaVita Inc.
IndexS&P 500 P/E9.89 EPS (ttm)8.40 Insider Own0.70% Shs Outstand96.34M Perf Week7.24%
Market Cap7.91B Forward P/E8.25 EPS next Y10.08 Insider Trans2.62% Shs Float91.83M Perf Month-12.88%
Income903.20M PEG1.20 EPS next Q2.09 Inst Own88.80% Short Float3.51% Perf Quarter-26.52%
Sales11.62B P/S0.68 EPS this Y39.30% Inst Trans-2.43% Short Ratio3.43 Perf Half Y-26.63%
Book/sh8.76 P/B9.49 EPS next Y28.01% ROA5.20% Target Price107.38 Perf Year-32.06%
Cash/sh3.65 P/C22.79 EPS next 5Y8.25% ROE89.70% 52W Range74.97 - 136.48 Perf YTD-26.94%
Dividend- P/FCF5.35 EPS past 5Y11.90% ROI15.40% 52W High-39.10% Beta1.21
Dividend %- Quick Ratio1.20 Sales past 5Y1.60% Gross Margin30.70% 52W Low10.86% ATR3.83
Employees69000 Current Ratio1.30 Sales Q/Q-0.10% Oper. Margin14.60% RSI (14)40.72 Volatility3.87% 4.47%
OptionableYes Debt/Eq10.52 EPS Q/Q-22.60% Profit Margin7.80% Rel Volume0.99 Prev Close79.96
ShortableYes LT Debt/Eq10.30 EarningsMay 05 AMC Payout0.00% Avg Volume940.25K Price83.11
Recom3.00 SMA20-4.82% SMA50-14.42% SMA200-22.92% Volume929,830 Change3.94%
Jun-21-22Reiterated BofA Securities Underperform $110 → $90
Sep-10-21Initiated Cowen Market Perform $145
Aug-12-21Downgrade Barclays Overweight → Equal Weight $135 → $146
Mar-26-21Downgrade BofA Securities Neutral → Underperform $127 → $118
Jan-05-21Downgrade BofA Securities Buy → Neutral $127
Jan-24-20Upgrade Goldman Neutral → Buy $72 → $97
Nov-07-19Downgrade Raymond James Outperform → Mkt Perform
Oct-25-19Downgrade Wolfe Research Outperform → Peer Perform
Sep-11-19Downgrade William Blair Outperform → Mkt Perform
Jul-26-19Downgrade Robert W. Baird Outperform → Neutral $70 → $65
Jan-08-19Upgrade UBS Sell → Neutral
Jan-03-19Initiated Deutsche Bank Buy $60
Dec-14-18Initiated Barclays Overweight
Nov-28-18Upgrade Raymond James Mkt Perform → Outperform
Nov-16-18Initiated UBS Sell $64
Nov-08-18Downgrade Raymond James Strong Buy → Mkt Perform
Sep-13-18Upgrade JP Morgan Underweight → Neutral
Jan-04-18Upgrade BofA/Merrill Neutral → Buy
Dec-12-17Upgrade Robert W. Baird Neutral → Outperform $63 → $82
Dec-11-17Upgrade Citigroup Neutral → Buy
Jun-30-22 05:52AM  
Jun-28-22 04:47PM  
Jun-23-22 08:44AM  
07:07AM  
Jun-22-22 04:02PM  
11:06AM  
Jun-21-22 05:35PM  
01:27PM  
01:21PM  
Jun-20-22 12:11PM  
11:16AM  
Jun-10-22 09:14AM  
Jun-06-22 12:53PM  
May-27-22 09:50AM  
May-26-22 10:54AM  
08:13AM  
07:06AM  
06:45AM  
May-23-22 08:00AM  
May-20-22 09:03AM  
May-13-22 06:17AM  
May-10-22 06:02AM  
May-09-22 06:02AM  
May-06-22 10:09AM  
09:00AM  
07:00AM  
May-05-22 06:18PM  
05:45PM  
04:05PM  
May-03-22 06:02AM  
May-02-22 10:01AM  
Apr-22-22 09:55AM  
Apr-21-22 07:12AM  
04:05AM  
Apr-19-22 04:43PM  
Apr-15-22 10:09PM  
07:57PM  
07:24PM  
Apr-13-22 08:39PM  
Apr-12-22 09:33AM  
Apr-11-22 09:00AM  
Apr-07-22 06:01PM  
Apr-05-22 09:28AM  
Apr-04-22 01:53PM  
09:20AM  
Mar-18-22 11:00AM  
09:04AM  
Mar-16-22 11:46AM  
10:55AM  
Mar-11-22 10:00AM  
Mar-04-22 09:21AM  
Mar-03-22 02:40PM  
Mar-01-22 06:22AM  
Feb-17-22 06:04AM  
Feb-16-22 06:02AM  
Feb-14-22 06:02AM  
Feb-11-22 10:39AM  
09:40AM  
01:01AM  
Feb-10-22 05:35PM  
04:05PM  
07:00AM  
Feb-09-22 10:52AM  
Feb-08-22 09:51AM  
06:17AM  
Feb-04-22 05:38PM  
03:58PM  
12:04PM  
Feb-03-22 03:01PM  
Feb-02-22 05:38PM  
09:00AM  
Feb-01-22 01:38PM  
Jan-31-22 05:38PM  
05:38PM  
Jan-28-22 09:38AM  
Jan-27-22 04:57PM  
04:05PM  
Jan-26-22 11:09AM  
Jan-21-22 01:38PM  
01:38PM  
Jan-19-22 01:38PM  
01:26PM  
11:52AM  
06:02AM  
Jan-18-22 06:02AM  
Jan-12-22 06:02AM  
Jan-10-22 01:38PM  
Jan-06-22 08:24AM  
06:02AM  
Dec-30-21 08:27AM  
Dec-28-21 09:47AM  
Dec-21-21 09:38PM  
Dec-16-21 06:02AM  
Dec-13-21 08:01AM  
Dec-10-21 10:15AM  
Dec-09-21 06:02AM  
Dec-08-21 08:24PM  
Dec-06-21 11:15AM  
Dec-04-21 07:33AM  
Nov-30-21 10:23AM  
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCJun 23Buy77.7020,0001,554,00061,190Jun 27 07:31 PM
Rodriguez JavierChief Executive OfficerJun 06Option Exercise65.4879,9095,232,441381,059Jun 07 06:47 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffJun 06Option Exercise65.4820,9291,370,43187,092Jun 07 06:47 PM
DESOER BARBARA JDirectorJun 03Sale97.422,320226,0100Jun 06 06:17 PM
DESOER BARBARA JDirectorMay 31Option Exercise66.177,178474,9687,178Jun 01 05:27 PM
NEHRA JOHN MDirectorMay 10Option Exercise66.177,178474,9687,178May 11 06:35 PM
HEARTY JAMES OChief Compliance OfficerMar 24Option Exercise65.482,283149,49117,228Mar 28 05:34 PM
Price Paula ADirectorFeb 14Sale113.6470079,551491Feb 15 06:24 PM
Arway Pamela MDirectorNov 23Sale102.8644645,87619,239Nov 23 05:34 PM
STAFFIERI MICHAEL DAVIDChief Operating Officer, DKCSep 03Option Exercise65.4837,1012,429,373117,783Sep 08 05:59 PM
Arway Pamela MDirectorAug 23Sale133.0936548,57819,239Aug 23 06:08 PM
ACKERMAN JOELCFO and TreasuerAug 09Option Exercise68.89145,15910,000,004180,659Aug 11 07:32 PM
Price Paula ADirectorAug 05Sale132.66790104,804380Aug 06 06:00 PM
ACKERMAN JOELCFO & TreasurerAug 05Sale131.3637,7604,960,14635,500Aug 06 06:00 PM